An in-depth understanding of how pTh2 cells are regulated will be crucial for developing novel therapies for pTh2-mediated allergic diseases including allergic asthma, allergic rhinitis, atopic dermatitis, eosinophilic esophagitis and food allergy. This evidence concerns the gene PTH2 and eosinophilic esophagitis.